Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 532

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

Open access
Murad, Sarwa Darwish, Plessier, Aurelie, Hernandez-Guerra, Manuel, Fabris, Federica, Eapen, Chundamannil E., Bahr, Matthias J., Trebicka, Jonel, Morard, Isabelle, Lasser, Luc, Heller, Joerg, Hadengue, Antoine, Langlet, Philippe, Miranda, Helena, Primignani, Massimo, Elias, Elwyn, Leebeek, Frank W., Rosendaal, Frits R., Garcia-Pagan, Juan-Carlos, Valla, Dominique C., Janssen, Harry L.A., for EN-Vie (European Network for Vascular Disorders of the Liver)* · 2009 · Annals of Internal Medicine

Abstract

BACKGROUND: The Budd-Chiari syndrome (BCS) is hepatic venous outflow obstruction. What is known about the syndrome is based on small studies of prevalent cases. OBJECTIVE: To characterize the causes and treatment of incident BCS. DESIGN: Consecutive case series of patients with incident BCS, enrolled from October 2003 to October 2005 and followed until May 2006. SETTING: Academic and nonacademic hospitals in France, Spain, Italy, Great Britain, Germany, Belgium, the Netherlands, Portugal, and Switzerland. PATIENTS: Persons older than 16 years with definite hepatic outflow obstruction diagnosed by imaging. Persons with hepatic outflow obstruction due to heart failure, sinusoidal obstruction syndrome, cancer, or liver transplantation were excluded. MEASUREMENTS: Signs and symptoms; laboratory and imaging findings; diagnosis; treatment; and overall, transplantation-free, and intervention-free survival. RESULTS: 163 incident cases of BCS were identified. Median follow-up was 17 months (range, 0.1 to 31 months). Most patients (84%) had at least 1 thrombotic risk factor, and many (46%) had more than 1; the most common was myeloproliferative disorders (49% of 103 tested patients). Patients were mainly treated with anticoagulation (140 patients [86%]), transjugular intrahepatic portosystemic shunting (56 patients [34%]), or liver transplantation (20 patients [12%]), and 80 patients (49%) were managed noninvasively. Only 3 patients underwent surgical shunting. The survival rate was 87% (95% CI, 82% to 93%) at 1 year and 82% (CI, 75% to 88%) at 2 years. LIMITATION: Treatment was not standardized across all centers, and data on important clinical variables were missing for some patients. CONCLUSION: Most patients with BCS have at least 1 thrombotic risk factor, and many have more than 1; myeloproliferative disorders are most common. One- and 2-year survival rates are good with contemporary management, which includes noninvasive therapies (anticoagulation and diuretics) and invasive techniques. Transjugular intrahepatic portosystemic shunting seems to have replaced surgical shunting as the most common invasive therapeutic procedure. PRIMARY FUNDING SOURCE: Fifth Framework Programme of the European Commission.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-151-3-200908040-00004

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 532

Metadata

Authors
Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., Hadengue, A., Langlet, P., Miranda, H., Primignani, M., Elias, E., Leebeek, F. W., Rosendaal, F. R., Garcia-Pagan, J.-C., Valla, D. C., Janssen, H. L. A., & for EN-Vie (European Network for Vascular Disorders of the Liver)*
Venue
Annals of Internal Medicine
Published
2009-08-04
Volume
151
Issue
3
Pages
167-175
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2153802696
Cited by
532
References
22
FWCI
16.70
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Etiology, Management, and Outcome of the Budd-Chiari Syndrome. https://app.cochat.ai/papers/10.7326/0003-4819-151-3-200908040-00004
The paper
Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., Hadengue, A., Langlet, P., Miranda, H., Primignani, M., Elias, E., Leebeek, F. W., Rosendaal, F. R., Garcia-Pagan, J.-C., Valla, D. C., . . . for EN-Vie (European Network for Vascular Disorders of the Liver)*. (2009). Etiology, Management, and Outcome of the Budd-Chiari Syndrome. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-151-3-200908040-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.